Seroprevailence of Antibody Titers Against Hepatitis B in Children Aged from 1 to 5 years old. Matanzas Province,1999.

Authors

  • Carmen G. Pérez Fundora Especialistas de I Grado en Epidemiología
  • Jesús Quintana Hernández Especialistas de I Grado en Epidemiología
  • Leovaldo Núñez Valdés Especialista de I Grado en Epidemiología..Profesor Instructor.
  • María T. Dihigo Faz Especialista de I Grado en Higiene.Profesora Instructora

Keywords:

VACUNAS CONTRA HEPATITISB, HUMANO-ADULTO

Abstract

In 1992 the vaccine against the Hepatitis B disease was first used in Cuba, in newborn chidren,following,all the necessary tests for its approval.The logical evolution of the same induces us to find ourselves in the phase or post marketing based on the maintenance evaluation og its protecting capacity.
In order to evaluate the permanency of antibidy titers against the Hepatitis B virus in children from one to five years old,previously vaccinated,a simple study of transversal cut has been carried out, belonging to the IV phase of the HB Herberbiovac,which implies the evaluation of and intervention in open populations.
One hundred eight three children werw studied within the health areas in East Colon and Perico Municipalities,171 of these children had titers above 10 VI per liter, ascending to a 93,4 % provincial efficacy. A 100% efficienciency resulted in children from one to three years old. A reinforcement dose was given to the twelve hyporesponders 9.8% were hyperresponders.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Pérez Fundora CG, Quintana Hernández J, Núñez Valdés L, Dihigo Faz MT. Seroprevailence of Antibody Titers Against Hepatitis B in Children Aged from 1 to 5 years old. Matanzas Province,1999. Rev Méd Electrón [Internet]. 2014 Feb. 11 [cited 2025 Apr. 24];24(3):149-53. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/47

Issue

Vol. 24 No. 3 (2002)

Section

Research article

License

All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.

It allows:

 - Copy and redistribute published material in any medium or format.

 - Adapt the content.

 This will be done under the following terms:

 - Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.

 - Non-commercial use.

 - Recognize the journal where it is published.

 The copyrights of each article are maintained, without restrictions.